Adults aged ≥65 years are recommended to receive pneumococcal vaccine

A single dose of a 21vPCV is recommended for all adults aged ≥65 years. 

Adults who have previously received a dose of any pneumococcal vaccine (including 23vPPV (23-valent pneumococcal polysaccharide vaccine), 13vPCV, 15vPCV or 20vPCV) are recommended to receive the dose of 21vPCV at least 12 months after their last dose. See Infographic. Pneumococcal vaccination for people who have previously received a pneumococcal vaccine.

Adults aged 18–64 years who receive a dose of 21vPCV due to a risk condition do not need another dose at 65 years of age. 

21vPCV is funded through the NIP for all adults aged ≥65 years. For details see the National Immunisation Program Schedule.